Literature DB >> 8254618

The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses.

V Tschinke1, N C Cohen.   

Abstract

We have developed a computer program, called NEWLEAD, for the automatic generation of candidate structures conforming to the requirements of a given pharmacophore. The treatment consists in connecting the pharmacophoric pieces with spacers assembled from small chemical entities (atoms, chains, or ring moieties). We have tested the program on several sets of input fragments, each comprising selected functional groups obtained from the bioactive conformations of reference molecules. In addition to the expected solutions, the program can generate new structures that are chemically unrelated to the reference molecules. This provides an unbiased starting point for the design of new generations of lead structures. The concept used in this approach is presented and discussed. The present possibilities of the program are illustrated by some examples. The treatment is very fast, because only a few bonds are created between building blocks already having ideal geometries. The ability to generate rapidly a variety of molecules conforming to a three-dimensional pharmacophoric model makes NEWLEAD a useful tool with wide applicability in rational drug design, including the areas of molecular mimicry and peptidomimetism.

Mesh:

Substances:

Year:  1993        PMID: 8254618     DOI: 10.1021/jm00076a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

2.  PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology.

Authors:  C W Murray; D E Clark; T R Auton; M A Firth; J Li; R A Sykes; B Waszkowycz; D R Westhead; S C Young
Journal:  J Comput Aided Mol Des       Date:  1997-03       Impact factor: 3.686

3.  Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design.

Authors:  N P Todorov; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1997-03       Impact factor: 3.686

4.  PRO-LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement.

Authors:  D R Westhead; D E Clark; D Frenkel; J Li; C W Murray; B Robson; B Waszkowycz
Journal:  J Comput Aided Mol Des       Date:  1995-04       Impact factor: 3.686

5.  PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides.

Authors:  D Frenkel; D E Clark; J Li; C W Murray; B RObson; B Waszkowycz; D R Westhead
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

6.  BUILDER v.2: improving the chemistry of a de novo design strategy.

Authors:  D C Roe; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

7.  PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules.

Authors:  D E Clark; D Frenkel; S A Levy; J Li; C W Murray; B Robson; B Waszkowycz; D R Westhead
Journal:  J Comput Aided Mol Des       Date:  1995-02       Impact factor: 3.686

8.  PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.

Authors:  C W Murray; D E Clark; D G Byrne
Journal:  J Comput Aided Mol Des       Date:  1995-10       Impact factor: 3.686

Review 9.  Current methods for site-directed structure generation.

Authors:  R A Lewis; A R Leach
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

10.  e-LEA3D: a computational-aided drug design web server.

Authors:  Dominique Douguet
Journal:  Nucleic Acids Res       Date:  2010-05-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.